RT Journal Article
SR Electronic
T1 Cis-platinum chemotherapy for ocular basal cell carcinoma.
JF British Journal of Ophthalmology
JO Br J Ophthalmol
FD BMJ Publishing Group Ltd.
SP 407
OP 410
DO 10.1136/bjo.75.7.407
VO 75
IS 7
A1 M. Morley
A1 P. T. Finger
A1 M. Perlin
A1 L. R. Weiselberg
A1 D. S. DeBlasio
YR 1991
UL http://bjo.bmj.com/content/75/7/407.abstract
AB We have used intravenous cis-platinum chemotherapy in the treatment of three patients with basal cell carcinoma of the lid extending into the orbit. Cis-platinum chemotherapy caused a reduction in tumour size and thereby delayed surgery in all cases. It allowed for local resection in one case, appeared to delay a patient's exenteration in a second case, and was used prior to radiotherapy in a third case. While not curative, cis-platinum may be useful as an adjuvant to decrease tumour mass prior to local excision and for patients who refuse or must delay exenteration.